STOCK TITAN

Cronos Group Inc. confirms receipt of unsolicited indications of interest

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Cronos Group Inc. confirms receiving unsolicited indications of interest from third parties for potential transactions. The company is reviewing these indications but no assurance of agreement or transaction. No further announcements unless required by law.
Positive
  • Cronos Group Inc. has received unsolicited indications of interest from third parties for potential transactions, which could positively impact the stock price if successful.
Negative
  • No concrete information is available about the potential transactions, so it is unclear if they will have a negative impact on the stock price.

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of interest from third parties, each regarding a potential transaction involving Cronos and the third party. Cronos is in the initial stages of reviewing these indications of interest, and there can be no assurance that any agreement or transaction will result therefrom. Cronos does not intend to make any further announcements regarding this matter unless and until required to do so by applicable law.

About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, and quarterly report on Form 10-Q for the quarter ended March 31, 2023, which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Contact
Shayne Laidlaw
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


FAQ

What is the news about Cronos Group Inc.?

Cronos Group Inc. has confirmed receiving unsolicited indications of interest from third parties for potential transactions.

What could be the impact of these potential transactions on the stock price?

If the potential transactions are successful, it could have a positive impact on the stock price.

Is there any guarantee of agreement or transaction?

No, there is no assurance that any agreement or transaction will result from the indications of interest.

Will there be any further announcements regarding this matter?

No further announcements will be made unless required by applicable law.

Cronos Group Inc. Common Share

NASDAQ:CRON

CRON Rankings

CRON Latest News

CRON Stock Data

800.88M
382.30M
46.4%
15.62%
1.29%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
STAYNER